Published in Cancer Gene Therapy Week, August 9th, 2010
"Hypoxic endothelial cells in ischemic tissues of solid tumors are important targets for gene therapy. A recombinant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Gene Therapy Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.